Skip to main content

FONDAPARINUX SODIUM

NDC 55150-230 · Eugia US LLC

Generic nameFONDAPARINUX SODIUM
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)FONDAPARINUX SODIUM
Strength2.5 mg/.5mL
Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
Marketing categoryANDA

Packages

55150-230-02 — 2 SYRINGE, GLASS in 1 CARTON (55150-230-02) / .5 mL in 1 SYRINGE, GLASS (55150-230-00)

55150-230-10 — 10 SYRINGE, GLASS in 1 CARTON (55150-230-10) / .5 mL in 1 SYRINGE, GLASS (55150-230-00)

Billed under HCPCS

J1652 — Injection, fondaparinux sodium, 0.5 mg Medicare Part B payment limit (ASP + 6%): $0.93

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0781-3465 — Fondaparinux Sodium, 0781-3476 — Fondaparinux Sodium, 11797-154 — fondaparinux sodium, 11797-155 — fondaparinux sodium, 11797-156 — fondaparinux sodium, 11797-157 — fondaparinux sodium, 55111-678 — Fondaparinux Sodium, 55111-679 — Fondaparinux Sodium, 55111-680 — Fondaparinux Sodium, 55111-681 — Fondaparinux Sodium, 55150-231 — FONDAPARINUX SODIUM, 55150-232 — FONDAPARINUX SODIUM, 55150-233 — FONDAPARINUX SODIUM, 67457-582 — fondaparinux sodium, 67457-583 — fondaparinux sodium, 67457-584 — fondaparinux sodium, 67457-585 — fondaparinux sodium, 67457-592 — fondaparinux sodium, 67457-593 — fondaparinux sodium, 67457-594 — fondaparinux sodium, +7 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.